Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Target validation and functional analyses using antisense oligonucleotides.

Margaret F Taylor1

  • 1Sequitur, Inc., 14 Tech Circle, Natick, MA 01760, USA. ptaylor@sequiturinc.com

Expert Opinion on Therapeutic Targets
|January 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why RNAi makes sense.

Nature biotechnology·2003
Same journal

The biological role of CCR4 and its ligands CCL17 and CCL22 in atopic dermatitis: therapeutic implications and future directions.

Expert opinion on therapeutic targets·2026
Same journal

Hepatocyte nuclear factor 4α - prospects for therapeutic targeting.

Expert opinion on therapeutic targets·2026
Same journal

The role of bile acid receptors in cholestatic liver disease: pathophysiological insights and therapeutic advances.

Expert opinion on therapeutic targets·2026
Same journal

Molecular insights for targeting the Nrf1 pathway in hepatocellular carcinoma.

Expert opinion on therapeutic targets·2026
Same journal

Transient receptor potential (TRP) channels: an emerging therapeutic target for the treatment of cardiac hypertrophy.

Expert opinion on therapeutic targets·2026
Same journal

The AT<sub>2</sub> receptor as a potential target for autosomal dominant polycystic kidney disease therapy?

Expert opinion on therapeutic targets·2026
See all related articles

The Human Genome Project (HGP) is advancing gene function identification. Antisense technologies are crucial tools for unlocking the human genome

Area of Science:

  • Genomics
  • Molecular Biology
  • Drug Discovery

Background:

  • The Human Genome Project (HGP) has generated a working draft of the human genome.
  • Identifying the function of approximately 30,000 human genes is the next major research focus.
  • Antisense oligomers are established tools for functional genomics and drug target validation.

Purpose of the Study:

  • To describe emerging and established antisense technologies.
  • To highlight the role of these technologies in understanding human gene function.
  • To identify novel drug targets for human diseases.

Main Methods:

  • Review of antisense technologies.
  • Application of antisense oligomers in functional genomics.
  • Utilizing antisense approaches for drug target validation.

Related Experiment Videos

Main Results:

  • Antisense technologies offer potent methods for gene function analysis.
  • These technologies facilitate the discovery of potential drug targets.
  • The HGP's data is being leveraged with antisense tools.

Conclusions:

  • Antisense technologies are vital for continued exploration of the human genome.
  • These methods are instrumental in advancing the discovery of treatments for human diseases.
  • The integration of HGP findings with antisense technology accelerates biomedical research.